butylscopolammonium bromide and Peritoneal Neoplasms
butylscopolammonium bromide has been researched along with Peritoneal Neoplasms in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hu, S; Li, S; Peng, X; Wang, P; Zhang, G | 1 |
Amthauer, H; Buchmann, E; Felix, R; Hosten, N; Ricke, J; Rieger, J; Sehouli, J; Stroszczynski, C | 1 |
Trials
1 trial(s) available for butylscopolammonium bromide and Peritoneal Neoplasms
Article | Year |
---|---|
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer.
Topics: Butylscopolammonium Bromide; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Intestinal Obstruction; Liver Neoplasms; Middle Aged; Neoplasm Staging; Octreotide; Ovarian Neoplasms; Parasympatholytics; Peritoneal Neoplasms; Pleural Neoplasms; Prognosis; Prospective Studies; Severity of Illness Index | 2015 |
Other Studies
1 other study(ies) available for butylscopolammonium bromide and Peritoneal Neoplasms
Article | Year |
---|---|
[Fat-saturated, contrast-enhanced spin-echo sequences in the magnetic resonance tomographic diagnosis of peritoneal carcinosis].
Topics: Adult; Aged; Butylscopolammonium Bromide; Carcinoma; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscarinic Antagonists; Peritoneal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 1999 |